I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 26% ± 8% | |
| retina horizontal cell | 3 studies | 27% ± 8% | |
| glutamatergic neuron | 3 studies | 37% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 26% ± 8% | |
| retina horizontal cell | 3 studies | 27% ± 8% | |
| glutamatergic neuron | 3 studies | 37% ± 4% |
Insufficient scRNA-seq data for expression of NAT14 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2754.48 | 2639 / 2642 | 100% | 67.46 | 705 / 705 |
| thymus | 100% | 1458.25 | 653 / 653 | 100% | 73.47 | 602 / 605 |
| ovary | 100% | 1313.91 | 180 / 180 | 96% | 31.34 | 413 / 430 |
| adrenal gland | 100% | 879.46 | 257 / 258 | 94% | 90.47 | 217 / 230 |
| prostate | 99% | 1062.21 | 243 / 245 | 94% | 21.39 | 474 / 502 |
| uterus | 100% | 1725.53 | 170 / 170 | 92% | 50.13 | 421 / 459 |
| kidney | 99% | 1169.65 | 88 / 89 | 92% | 37.58 | 830 / 901 |
| bladder | 100% | 810.95 | 21 / 21 | 87% | 32.01 | 440 / 504 |
| skin | 84% | 672.00 | 1516 / 1809 | 100% | 61.32 | 472 / 472 |
| lung | 96% | 738.16 | 555 / 578 | 88% | 26.13 | 1012 / 1155 |
| breast | 82% | 525.87 | 377 / 459 | 96% | 38.60 | 1075 / 1118 |
| pancreas | 62% | 263.01 | 204 / 328 | 95% | 34.27 | 169 / 178 |
| intestine | 92% | 941.37 | 889 / 966 | 62% | 12.82 | 327 / 527 |
| stomach | 87% | 556.94 | 311 / 359 | 52% | 9.78 | 149 / 286 |
| esophagus | 82% | 653.24 | 1188 / 1445 | 51% | 8.49 | 93 / 183 |
| eye | 0% | 0 | 0 / 0 | 100% | 97.55 | 80 / 80 |
| ureter | 0% | 0 | 0 / 0 | 100% | 29.32 | 1 / 1 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 30.44 | 28 / 29 |
| spleen | 94% | 454.19 | 226 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 22.32 | 38 / 45 |
| heart | 80% | 419.97 | 693 / 861 | 0% | 0 | 0 / 0 |
| liver | 35% | 127.14 | 80 / 226 | 37% | 9.87 | 151 / 406 |
| adipose | 71% | 300.66 | 849 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 67% | 330.82 | 900 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 22% | 179.82 | 207 / 929 | 0% | 0 | 0 / 0 |
| muscle | 5% | 14.74 | 38 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0006352 | Biological process | DNA-templated transcription initiation |
| GO_0016020 | Cellular component | membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0008080 | Molecular function | N-acetyltransferase activity |
| Gene name | NAT14 |
| Protein name | Probable N-acetyltransferase 14 (EC 2.3.1.-) (K562 cell-derived leucine-zipper-like protein 1) N-acetyltransferase 14 (putative) Probable N-acetyltransferase 14 |
| Synonyms | KLP1 |
| Description | FUNCTION: Probable acetyltransferase. .; FUNCTION: May act as a transcription factor that regulates the expression of coproporphyrinogen oxidase by binding to a promoter regulatory element. . FUNCTION: Probable acetyltransferase. . |
| Accessions | ENST00000591590.1 M0R1E3 Q8WUY8 ENST00000588985.1 ENST00000587400.1 ENST00000205194.5 M0R284 M0QZH3 |
